Document is current
Any future updates will be listed below
-
Authors
Nazir, Muhummad Sohaib https://orcid.org/0000-0003-2749-1033
Hughes, Daniel Johnathan
Chand, Gitasha
Adamson, Kathryn
Johnson, Jessica
Bailey, Damion
Gibson, Victoria
Ting, Hong Hoi
Lyon, Alexander R.
Cook, Gary J. R.
,
Edmonds, Scott
Georgiou, Alexandros
Karapanagiotou, Eleni
Josephs, Debra
McLean, Emma
Spicer, James
Goh, Vicky
-
Funding
Funding for this research was provided by:
National Institute for Health Research Health Protection Research Unit (CL-2019-17-001)
- License Information
-
More Information
Article History
Received: 15 February 2023
Accepted: 26 April 2023
First Online: 17 May 2023
Declarations
:
: The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments. Participants provided written informed consent and the study was conducted with approval from the United Kingdom Research Ethics Committee and Health Research Authority (reference 256684). All patients provided written informed consent to participate.
: All patients consented for the use of their data for this study.
: DJH has received speaker fees and/or travel reimbursement from Novartis, Pfizer and BMS; DJH and GJRC have received research funding via institution from Nanomab Technology (UK) Ltd; GJRC has received consultation fees and radiotracer for research from Nanomab Technology (UK) Ltd. GC and HHT are employees of Nanomab Technology (UK) Ltd. All other authors have no relevant disclosures.
